Roche’s COVID-19 antibody test gets FDA emergency authorisation
Swiss pharma giant Roche has received Emergency Use Authorisation (EUA) from the FDA for its latest COVID-19 antibody test –
Read moreRead the latest pharmaceutical industry press releases, news updates and articles on coronavirus COVID-19 medical treatment, therapies and drug and vaccine development.
Swiss pharma giant Roche has received Emergency Use Authorisation (EUA) from the FDA for its latest COVID-19 antibody test –
Read moreThe U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for emergency use of Gilead’s remdesivir
Read moreModerna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read moreUK-headquartered AstraZeneca and Oxford University announced an agreement to develop and distribute the university’s future recombinant adenovirus vaccine to prevent
Read moreRemdesivir, an investigational nucleotide analog with broad-spectrum antiviral activity developed by the Californian biopharmaceutical company Gilead Sciences, has shown promising
Read moreNubilaria is providing it’s innovative ACTide EDC system free in support of a clinical study for COVID-19 related ARDS intensive
Read moreARTES Biotechnology, a Germany-based biotechnology company specialising in process development for recombinant vaccines, has commenced the development of SARS-CoV-2 vaccine
Read moreWhile COVID-19 transmission is expanding, the Japanese government has agreed to raise its Avigan® Tablet (favipiravir) stockpile, which is estimated
Read moreItalian IT and complex database consultancy Nubilaria is offering it’s cutting edge ACTide EDC web platform free of charge to
Read moreAt the end of March, the American medical devices and healthcare company Abbott Laboratories announced that the U.S. Food and
Read more